{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:46:00Z","timestamp":1792093560709,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["GA\u02c7CR19-13946S"],"award-info":[{"award-number":["GA\u02c7CR19-13946S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.12.022","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T20:39:55Z","timestamp":1607546395000},"page":"495-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic"],"prefix":"10.1016","volume":"39","author":[{"given":"Mehdi","family":"Rastegar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-1723","authenticated-orcid":false,"given":"Madjid","family":"Tavana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Meraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"34","key":"10.1016\/j.vaccine.2020.12.022_b0005","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.1016\/j.vaccine.2020.06.016","article-title":"Landscape analysis of pharmacovigilance and related practices among 34 vaccine manufacturers\u2019 from emerging countries","volume":"38","author":"Hartmann","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.12.022_b0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10729-006-0001-5","article-title":"An analysis of the pediatric vaccine supply shortage problem","volume":"9","author":"Jacobson","year":"2006","journal-title":"Health Care Management Science"},{"issue":"6","key":"10.1016\/j.vaccine.2020.12.022_b0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/14760584.6.6.981","article-title":"Survey of vaccine distribution and delivery issues in the USA: from pediatrics to pandemics","volume":"6","author":"Jacobson","year":"2007","journal-title":"Expert review of vaccines"},{"key":"10.1016\/j.vaccine.2020.12.022_b0020","doi-asserted-by":"crossref","unstructured":"Peter, G., Arvin, A. M., Davis, J. P., & Decker, M. D. (2003). Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. JAMA, 290(23), 3122-3122.","DOI":"10.1001\/jama.290.23.3122"},{"issue":"Supplement_3","key":"10.1016\/j.vaccine.2020.12.022_b0025","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1086\/499591","article-title":"The United States pediatric vaccine stockpile program","volume":"42","author":"Lane","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Supplement_3","key":"10.1016\/j.vaccine.2020.12.022_b0030","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/499587","article-title":"Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention","volume":"42","author":"Rodewald","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.022_b0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejor.2018.01.015","article-title":"Literature review: The vaccine supply chain","volume":"268","author":"Duijzer","year":"2018","journal-title":"Eur J Oper Res"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.022_b0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.puhe.2007.06.005","article-title":"A systematic analysis of influenza vaccine shortage policies","volume":"122","author":"Uscher-Pines","year":"2008","journal-title":"Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.022_b0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1471-2458-7-236","article-title":"Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review","volume":"7","author":"Straetemans","year":"2007","journal-title":"BMC Public Health"},{"issue":"38","key":"10.1016\/j.vaccine.2020.12.022_b0050","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1016\/j.vaccine.2010.06.095","article-title":"Modeling the national pediatric vaccine stockpile: Supply shortages, health impacts and cost consequences","volume":"28","author":"Shrestha","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2020.12.022_b0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejor.2012.05.003","article-title":"Reservation and allocation policies for influenza vaccines","volume":"222","author":"Samii","year":"2012","journal-title":"Eur J Oper Res"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.022_b0060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.dss.2012.05.007","article-title":"A decision support system for patient scheduling in travel vaccine administration","volume":"54","author":"Abrahams","year":"2012","journal-title":"Decis Support Syst"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.022_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2008-2231-20-19","article-title":"Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study","volume":"20","author":"Meshkini","year":"2012","journal-title":"DARU Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.vaccine.2020.12.022_b0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.orhc.2014.09.002","article-title":"The top ten global health supply chain issues: perspectives from the field","volume":"3","author":"Privett","year":"2014","journal-title":"Operations Research for Health Care"},{"key":"10.1016\/j.vaccine.2020.12.022_b0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tre.2014.04.001","article-title":"An accelerated Benders decomposition algorithm for sustainable supply chain network design under uncertainty: A case study of medical needle and syringe supply chain","volume":"67","author":"Pishvaee","year":"2014","journal-title":"Transportation Research Part E: Logistics and Transportation Review"},{"issue":"29","key":"10.1016\/j.vaccine.2020.12.022_b0080","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.vaccine.2015.03.042","article-title":"Outsourcing vaccine logistics to the private sector: the evidence and lessons learned from the Western Cape Province in South-Africa","volume":"33","author":"Lydon","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.022_b0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejor.2015.10.056","article-title":"Cold supply chain design with environmental considerations: A simulation-optimization approach","volume":"251","author":"Saif","year":"2016","journal-title":"Eur J Oper Res"},{"issue":"4","key":"10.1016\/j.vaccine.2020.12.022_b0090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.vaccine.2017.12.010","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccine: a global assessment of demand and supply balance","volume":"36","author":"Cernuschi","year":"2018","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2020.12.022_b0095","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1016\/j.vaccine.2019.06.006","article-title":"Impact of vaccine stockouts on immunization coverage in Nigeria","volume":"37","author":"Gooding","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.12.022_b0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejor.2019.11.005","article-title":"Cold chain transportation decision in the vaccine supply chain","volume":"283","author":"Lin","year":"2020","journal-title":"Eur J Oper Res"},{"key":"10.1016\/j.vaccine.2020.12.022_b0105","first-page":"1","article-title":"A chance constrained fuzzy goal programming approach for perishable pharmaceutical supply chain network design","author":"Zandkarimkhani","year":"2020","journal-title":"Ann Oper Res"},{"issue":"2","key":"10.1016\/j.vaccine.2020.12.022_b0110","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejor.2019.11.025","article-title":"Optimal influenza vaccine distribution with equity","volume":"283","author":"Enayati","year":"2020","journal-title":"Eur J Oper Res"},{"key":"10.1016\/j.vaccine.2020.12.022_b0115","unstructured":"World Health Organization, Influenza (seasonal), November https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal), (2018), Accessed date: 9 May 2020."},{"key":"10.1016\/j.vaccine.2020.12.022_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.earlhumdev.2020.105116","article-title":"Influenza vaccination in the COVID-19 era","volume":"148","author":"Grech","year":"2020","journal-title":"Early Human Dev"},{"key":"10.1016\/j.vaccine.2020.12.022_b0125","article-title":"Roadmap for strengthening the vaccine supply chain in emerging countries: Manufacturers\u2019 perspectives","volume":"100068","author":"Jarrett","year":"2020","journal-title":"Vaccine:X"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:51:54Z","timestamp":1759402314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20315899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20315899"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}